Key facts
- Healthera’s last known valuation is $15.5M (Apr 2025).
- It has raised $8.3M; the latest was Later Stage VC ($3.7M) in Apr 2025.
- Notable investors include Innovate UK, MassChallenge, Tech Nation Group, Parkwalk Advisors, Cambridge Enterprise Ventures — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Healthera
- ·The full record, as it builds
Funding rounds
No funding rounds for Healthera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Healthera
Developer of a health management application designed to connect patients with pharmacists. The company's application allows users to send reminders about medication timings, connect with local pharmacies to order prescriptions, from the pharmacy and message a pharmacist anytime, anywhere, providing patients with medicine delivery and personalized medical care.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2015
- Employees
- 38
- Website
- healthera.co.uk/
- Ownership
- Privately Held (backing)
Healthera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Healthera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Healthera in its N-PORT filings yet. We sweep new filings monthly.